申请人:Cho Aesop
公开号:US20120156166A1
公开(公告)日:2012-06-21
Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
提供的是I式化合物及其药学上可接受的盐和酯。所提供的化合物、组合物和方法对于治疗黄病毒科病毒感染,特别是丙型肝炎感染具有有用的作用。